Skip to main content

Table 3 Laboratory parameters in the studied groups at the baseline and after 3 months

From: Different vitamin K forms in hemodialysis patients: a simple dietary supplement to battle vascular calcification—randomized controlled trial

 

Vitamin k1

Vitamin K2

Placebo

ANOVA

Mean ±SD

Range

Mean ±SD

Range

Mean ±SD

Range

F

P-value

Baseline PTH (pg/ml)

618±598.07

15–3380

690.88±535.81

20–2024

570 ±457.742

49–2357

0.52

0.596

Baseline Ca+ (mg/dl)

8.845±1.09

6.3–11.3

8.525±0.793

6.6–10.4

8.685±0.689

7.5–10.4

1.341

0.266

3 months Ca+ (mg/dl)

8.82±1.227

5.3–11.3

8.555±0.981

4.9–10.3

8.768±1.048

4.8–11.3

0.663

0.517

Differences

0.025±0.801

 

(− 0.03±0.633)

 

(− 0.083±0.834)

   

P-value

0.845

 

0.766

 

0.535

   

BaselinePO4 (mg/dl)

4.3±1.759

0.8–10

4.543±1.791

2.2–10.3

4.865±1.649

1.8–8.6

1.069

0.347

3 monthsPO4 (mg/dl)

4.25±1.974

1.2–9.6

4.263±1.572

2.2–8.5

4.13±1.399

1.5–7.7

0.077

0.926

Differences

0.05±1.334

 

0.28±1.21

 

0.735±1.355

   

P-value

0.814

 

0.151

 

0.001*

   

BaselineCa2+ and PO4 product

37.639±15.859

9.04–88

39.106±17.858

17.82–107.12

42.101±14.386

16.56–76.54

0.799

0.452

3 months Ca2+ and PO4 product

37.35±19.267

11.76–99.84

36.817±15.621

16.94–73.47

36.182±13.359

16.95–74.69

0.052

0.95

Differences

0.289±11.438

 

2.289±10.97

 

5.92±11.105

   

p-value

0.874

 

0.195

 

0.002*